Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine-Reference-Cited by-同舟云学术

Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine

Published:2024-03-23 Issue:5 Volume:41 Page:1983-1994
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Kwan Angela T. H.,Guo Ziji,Ceban Felicia,Le Gia Han,Wong Sabrina,Teopiz Kayla M.,Rhee Taeho Greg,Ho Roger,Di Vincenzo Joshua D.,Badulescu Sebastian,Meshkat Shakila,Cao Bing,Rosenblat Joshua D.,d’Andrea Giacomo,Dev Donovan A.,Phan Lee,Subramaniapillai Mehala,McIntyre Roger S.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02826-9.pdf

Reference30 articles.

1. McIntyre RS, Rasgon NL, Kemp DE, et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009;9(1):51–9.

2. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–90.

3. Cruz Neto J, Frota Cavalcante T, de Carvalho Félix ND. Post-COVID-19 metabolic syndrome: a new challenge for nursing care. Invest Educ Enferm. 2023. https://doi.org/10.17533/udea.iee.v41n1e01.

4. Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881–95.e20.

5. Siddiqi HK, Libby P, Ridker PM. COVID-19—a vascular disease. Trends Cardiovasc Med. 2021;31(1):1–5.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence, determinants, and consequences of post‐COVID in healthcare workers: A cross‐sectional survey;Journal of Medical Virology;2024-06